Immunostimulant compositions comprising an aminoalkyl...

Details Immunostimulant compositions comprising an aminoalkyl... Immunostimulant compositions comprising an aminoalkyl...

2006-04-18

2006-04-18

Wang, Shengjun (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S025000, C424S278100, C424S281100, C424S282100, C424S400000

Reexamination Certificate

active

07030094

ABSTRACT:
The invention provides pharmaceutical compositions, particularly vaccine compositions, employing an adjuvant system comprising RC-529 (an aminoalkyl glucosaminide phosphate compound) and QS-21 (a saponin). Such compositions synergistically enhance the immune response in a mammal to a co-administered antigen. Also provided are methods of using the compositions in the treatment of various human diseases, including cancer, microbial infections and autoimmune disorders.

REFERENCES:
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5750110 (1998-05-01), Prieels et al.
patent: 5972339 (1999-10-01), Walker
patent: 5977081 (1999-11-01), Marciani
patent: 6080725 (2000-06-01), Marciani
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6145632 (2000-11-01), Momin et al.
patent: 6146632 (2000-11-01), Momin et al.
patent: 6262029 (2001-07-01), Press et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6355257 (2002-03-01), Johnson et al.
patent: WO 98/50399 (1998-11-01), None
patent: WO 98/57659 (1998-12-01), None
patent: WO 99/62647 (1999-10-01), None
patent: WO 01/78777 (2001-10-01), None
U.S. Appl. No. 10/068,171, filed Feb. 4, 2002: Mossman et al., Immunostimulant Compositions Comprising Aminoalkyl Glocosaminide Phosphates and Saponins (copending application; not yet published).
U.S. Appl. No. 10/068,475, filed Feb. 4, 2002: Mossman et al., Immunostimulant Compositions Comprising Aminoalkyl Glocosaminide Phosphates and Saponins (copending application; not yet published).
Wijburg et al., The Role of Macrophages in the Induction and Regulation of Immunity Elecited by Exogenous Antigens; Eur. J. Immunol. 28: 479 (1998).
Jones et al., Immunization with Human Immunodeficiency Virus Type 1 rgp120W61Din QS21/MPL Adjuvant . . . ; J. Infect. Diseases 179: 558 (1999).
Mioore et al., The Adjuvant Combnation Mononphosphoryl Lipid A and QS21 switches T cell responses . . . ; Vaccine 17: 2517 (1999).
McCormack et al., A Phase I Trial in Negative Healthy Volunteers . . . ; Vaccine 18: 1166 (2000).
Gerard et al., Therapeutic Potential of OProtein and Adjuvant Vaccinations on Tumor Growth; Vaccine 19: 2583 (2001).
Johnson et al., Synthesis and Biolgical Evaluation of a New Class of Vaccine Adjuvants: Aminoalkyl Glucosaminide 4-Phosphates (AGPs): Bioorganic & Medicinal Chemistry Letters 9: 2273 (1999).

Affiliated with

Also associated with

Rating

Immunostimulant compositions comprising an aminoalkyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunostimulant compositions comprising an aminoalkyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulant compositions comprising an aminoalkyl... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3568410